Aim: The present study seeks to provide insight into the management of patients with chronic kidney disease (CKD) infected with COVID-19.
Material and methods: Patients with COVID-19 were included in the study if they met the inclusion criteria. 78 eligible patients were divided into four groups. After reviewing clinical charts, nursing records, laboratory findings, radiological reports and other medical records of CKD patients with COVID-19 confirmed infection, clinical presentation, laboratory data, radiology findings, and results were extracted from documented medical records using data collection forms. laboratory tests were performed again before discharge. Independent t-test, paired t-test, and chi-square were used to compare the clinical features of patients with COVID-19. A P< 0.05 was considered to indicate statistical significance. All the statistical analyses were performed by the SPSS. v 26.0.
Results: Hypertension (72.5%), diabetes (63.8%), and Cardiovascular disease (38.2%) were the most common among patients, respectively. Among all participants, 40 (52.6%) patients died. The most common symptom was dyspnea (56.6%), followed by dry cough (38.7%). Comparison of blood, inflammatory, biochemical, and clinical indices between the four groups in patients show that LDH (P=0.022), AST (P=0.038), and ALT (P= 0.004) indices were significantly different between groups of patients. According to the results in Table 3, Unilateral ground-glass opacity (GGO) in the radiological findings of the Non-dialysis CKD group was significantly (P=0.50) higher than the other groups.
Conclusion: It can be concluded that CKD is an important factor that can cause poor prognosis in COVID-19 patients.